> top > docs > PubMed:22859398 > annotations

PubMed:22859398 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-114 Sentence denotes Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
T2 115-126 Sentence denotes BACKGROUND:
T3 127-383 Sentence denotes To evaluate the association of variation in genes involved in immune response, including IL10, production and detoxification of reactive oxygen species, and repair of oxidative DNA damage with risk of recurrence after surgery for localized prostate cancer.
T4 384-392 Sentence denotes METHODS:
T5 393-489 Sentence denotes We conducted a nested case-control study of men who had a radical prostatectomy in 1993 to 2001.
T6 490-597 Sentence denotes A total of 484 recurrence cases and 484 controls were matched on age, race, and pathologic stage and grade.
T7 598-671 Sentence denotes Germline DNA was extracted from paraffin-embedded unaffected lymph nodes.
T8 672-907 Sentence denotes We genotyped candidate single-nucleotide polymorphisms (SNP) in IL10, CRP, GPX1, GSR, GSTP1, hOGG1, IL1B, IL1RN, IL6, IL8, MPO, NOS2, NOS3, SOD1, SOD2, SOD3, TLR4, and TNF and tagging SNPs in IL10, CRP, GSR, IL1RN, IL6, NOS2, and NOS3.
T9 908-997 Sentence denotes We used conditional logistic regression to estimate OR and 95% confidence intervals (CI).
T10 998-1006 Sentence denotes RESULTS:
T11 1007-1160 Sentence denotes The minor allele (A) in IL10 rs1800872, known to produce less interleukin-10 (IL-10), was associated with a higher risk of recurrence (OR = 1.76, 95% CI:
T12 1161-1307 Sentence denotes 1.00-3.10), and the minor allele (G) in rs1800896, known to produce more IL-10, was associated with a lower risk of recurrence (OR = 0.66, 95% CI:
T13 1308-1319 Sentence denotes 0.48-0.91).
T14 1320-1393 Sentence denotes We also observed associations for candidate SNPs in CRP, GSTP1, and IL1B.
T15 1394-1479 Sentence denotes A common IL10 haplotype and 2 common NOS2 haplotypes were associated with recurrence.
T16 1480-1491 Sentence denotes CONCLUSION:
T17 1492-1630 Sentence denotes Variation in IL10, CRP, GSTP1, IL1B, and NOS2 was associated with prostate cancer recurrence independent of pathologic prognostic factors.
T18 1631-1638 Sentence denotes IMPACT:
T19 1639-1827 Sentence denotes This study supports that genetic variation in immune response and oxidation influence prostate cancer recurrence risk and suggests genetic variation in these pathways may inform prognosis.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
9090 13-17 GeneOrGeneProduct denotes IL10 NCBIGene:3586
9091 87-102 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471
9092 216-220 GeneOrGeneProduct denotes IL10 NCBIGene:3586
9093 255-278 ChemicalEntity denotes reactive oxygen species MESH:D017382
9094 367-382 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471
9095 437-440 OrganismTaxon denotes men NCBITaxon:9606
9096 630-638 ChemicalEntity denotes paraffin MESH:D010232
9097 736-740 GeneOrGeneProduct denotes IL10 NCBIGene:3586
9098 742-745 GeneOrGeneProduct denotes CRP NCBIGene:1401
9099 747-751 GeneOrGeneProduct denotes GPX1 NCBIGene:2876
9100 753-756 GeneOrGeneProduct denotes GSR NCBIGene:2936
9101 758-763 GeneOrGeneProduct denotes GSTP1 NCBIGene:2950
9102 765-770 GeneOrGeneProduct denotes hOGG1 NCBIGene:4968
9103 772-776 GeneOrGeneProduct denotes IL1B NCBIGene:3553
9104 778-783 GeneOrGeneProduct denotes IL1RN NCBIGene:3557
9105 785-788 GeneOrGeneProduct denotes IL6 NCBIGene:3569
9106 790-793 GeneOrGeneProduct denotes IL8 NCBIGene:3576
9107 795-798 GeneOrGeneProduct denotes MPO NCBIGene:4353
9108 800-804 GeneOrGeneProduct denotes NOS2 NCBIGene:4843
9109 806-810 GeneOrGeneProduct denotes NOS3 NCBIGene:4846
9110 812-816 GeneOrGeneProduct denotes SOD1 NCBIGene:6647
9111 818-822 GeneOrGeneProduct denotes SOD2 NCBIGene:6648
9112 824-828 GeneOrGeneProduct denotes SOD3 NCBIGene:6649
9113 830-834 GeneOrGeneProduct denotes TLR4 NCBIGene:7099
9114 840-843 GeneOrGeneProduct denotes TNF NCBIGene:7124
9115 864-868 GeneOrGeneProduct denotes IL10 NCBIGene:3586
9116 870-873 GeneOrGeneProduct denotes CRP NCBIGene:1401
9117 875-878 GeneOrGeneProduct denotes GSR NCBIGene:2936
9118 880-885 GeneOrGeneProduct denotes IL1RN NCBIGene:3557
9119 887-890 GeneOrGeneProduct denotes IL6 NCBIGene:3569
9120 892-896 GeneOrGeneProduct denotes NOS2 NCBIGene:4843
9121 902-906 GeneOrGeneProduct denotes NOS3 NCBIGene:4846
9122 1031-1035 GeneOrGeneProduct denotes IL10 NCBIGene:3586
9123 1036-1045 SequenceVariant denotes rs1800872 DBSNP:rs1800872
9124 1069-1083 GeneOrGeneProduct denotes interleukin-10 NCBIGene:3586
9125 1085-1090 GeneOrGeneProduct denotes IL-10 NCBIGene:3586
9126 1201-1210 SequenceVariant denotes rs1800896 DBSNP:rs1800896
9127 1234-1239 GeneOrGeneProduct denotes IL-10 NCBIGene:3586
9128 1372-1375 GeneOrGeneProduct denotes CRP NCBIGene:1401
9129 1377-1382 GeneOrGeneProduct denotes GSTP1 NCBIGene:2950
9130 1388-1392 GeneOrGeneProduct denotes IL1B NCBIGene:3553
9131 1403-1407 GeneOrGeneProduct denotes IL10 NCBIGene:3586
9132 1431-1435 GeneOrGeneProduct denotes NOS2 NCBIGene:4843
9133 1505-1509 GeneOrGeneProduct denotes IL10 NCBIGene:3586
9134 1511-1514 GeneOrGeneProduct denotes CRP NCBIGene:1401
9135 1516-1521 GeneOrGeneProduct denotes GSTP1 NCBIGene:2950
9136 1523-1527 GeneOrGeneProduct denotes IL1B NCBIGene:3553
9137 1533-1537 GeneOrGeneProduct denotes NOS2 NCBIGene:4843
9138 1558-1573 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471
9139 1725-1740 DiseaseOrPhenotypicFeature denotes prostate cancer MESH:D011471

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 87-102 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T2 96-102 DiseaseOrPhenotypicFeature denotes cancer 0004992
T3 367-382 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T4 376-382 DiseaseOrPhenotypicFeature denotes cancer 0004992
T5 1558-1573 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T6 1567-1573 DiseaseOrPhenotypicFeature denotes cancer 0004992
T7 1725-1740 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T8 1734-1740 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 1036-1045 SequenceVariant denotes rs1800872
T2 1201-1210 SequenceVariant denotes rs1800896

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes IL10
T2 22-27 GeneOrGeneProduct denotes other
T3 50-56 GeneOrGeneProduct denotes immune
T4 189-195 GeneOrGeneProduct denotes immune
T5 216-220 GeneOrGeneProduct denotes IL10
T6 222-232 GeneOrGeneProduct denotes production
T7 308-314 GeneOrGeneProduct denotes damage
T8 384-391 GeneOrGeneProduct denotes METHODS
T9 408-414 GeneOrGeneProduct denotes nested
T10 415-419 GeneOrGeneProduct denotes case
T11 445-450 GeneOrGeneProduct denotes had a
T12 492-497 GeneOrGeneProduct denotes total
T13 516-521 GeneOrGeneProduct denotes cases
T14 560-564 GeneOrGeneProduct denotes race
T15 659-664 GeneOrGeneProduct denotes lymph
T16 665-670 GeneOrGeneProduct denotes nodes
T17 736-740 GeneOrGeneProduct denotes IL10
T18 747-751 GeneOrGeneProduct denotes GPX1
T19 758-763 GeneOrGeneProduct denotes GSTP1
T20 765-770 GeneOrGeneProduct denotes hOGG1
T21 772-776 GeneOrGeneProduct denotes IL1B
T22 778-783 GeneOrGeneProduct denotes IL1RN
T23 785-788 GeneOrGeneProduct denotes IL6
T24 790-793 GeneOrGeneProduct denotes IL8
T25 800-804 GeneOrGeneProduct denotes NOS2
T26 806-810 GeneOrGeneProduct denotes NOS3
T27 812-816 GeneOrGeneProduct denotes SOD1
T28 818-822 GeneOrGeneProduct denotes SOD2
T29 824-828 GeneOrGeneProduct denotes SOD3
T30 830-834 GeneOrGeneProduct denotes TLR4
T31 864-868 GeneOrGeneProduct denotes IL10
T32 880-885 GeneOrGeneProduct denotes IL1RN
T33 887-890 GeneOrGeneProduct denotes IL6
T34 892-896 GeneOrGeneProduct denotes NOS2
T35 902-906 GeneOrGeneProduct denotes NOS3
T36 1011-1016 GeneOrGeneProduct denotes minor
T37 1031-1035 GeneOrGeneProduct denotes IL10
T38 1069-1083 GeneOrGeneProduct denotes interleukin-10
T39 1085-1090 GeneOrGeneProduct denotes IL-10
T40 1181-1186 GeneOrGeneProduct denotes minor
T41 1234-1239 GeneOrGeneProduct denotes IL-10
T42 1377-1382 GeneOrGeneProduct denotes GSTP1
T43 1388-1392 GeneOrGeneProduct denotes IL1B
T44 1403-1407 GeneOrGeneProduct denotes IL10
T45 1418-1423 GeneOrGeneProduct denotes and 2
T46 1431-1435 GeneOrGeneProduct denotes NOS2
T47 1505-1509 GeneOrGeneProduct denotes IL10
T48 1516-1521 GeneOrGeneProduct denotes GSTP1
T49 1523-1527 GeneOrGeneProduct denotes IL1B
T50 1533-1537 GeneOrGeneProduct denotes NOS2
T51 1622-1629 GeneOrGeneProduct denotes factors
T52 1631-1637 GeneOrGeneProduct denotes IMPACT
T53 1685-1691 GeneOrGeneProduct denotes immune

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes IL10
T2 22-27 GeneOrGeneProduct denotes other
T3 216-220 GeneOrGeneProduct denotes IL10
T4 408-414 GeneOrGeneProduct denotes nested
T5 560-564 GeneOrGeneProduct denotes race
T6 736-740 GeneOrGeneProduct denotes IL10
T7 747-751 GeneOrGeneProduct denotes GPX1
T8 758-763 GeneOrGeneProduct denotes GSTP1
T9 765-770 GeneOrGeneProduct denotes hOGG1
T10 772-776 GeneOrGeneProduct denotes IL1B
T11 778-783 GeneOrGeneProduct denotes IL1RN
T12 785-788 GeneOrGeneProduct denotes IL6
T13 790-793 GeneOrGeneProduct denotes IL8
T14 800-804 GeneOrGeneProduct denotes NOS2
T15 806-810 GeneOrGeneProduct denotes NOS3
T16 812-816 GeneOrGeneProduct denotes SOD1
T17 818-822 GeneOrGeneProduct denotes SOD2
T18 824-828 GeneOrGeneProduct denotes SOD3
T19 830-834 GeneOrGeneProduct denotes TLR4
T20 864-868 GeneOrGeneProduct denotes IL10
T21 880-885 GeneOrGeneProduct denotes IL1RN
T22 887-890 GeneOrGeneProduct denotes IL6
T23 892-896 GeneOrGeneProduct denotes NOS2
T24 902-906 GeneOrGeneProduct denotes NOS3
T25 1011-1016 GeneOrGeneProduct denotes minor
T26 1031-1035 GeneOrGeneProduct denotes IL10
T27 1069-1083 GeneOrGeneProduct denotes interleukin-10
T28 1085-1090 GeneOrGeneProduct denotes IL-10
T29 1181-1186 GeneOrGeneProduct denotes minor
T30 1234-1239 GeneOrGeneProduct denotes IL-10
T31 1377-1382 GeneOrGeneProduct denotes GSTP1
T32 1388-1392 GeneOrGeneProduct denotes IL1B
T33 1403-1407 GeneOrGeneProduct denotes IL10
T34 1431-1435 GeneOrGeneProduct denotes NOS2
T35 1505-1509 GeneOrGeneProduct denotes IL10
T36 1516-1521 GeneOrGeneProduct denotes GSTP1
T37 1523-1527 GeneOrGeneProduct denotes IL1B
T38 1533-1537 GeneOrGeneProduct denotes NOS2
T39 1631-1637 GeneOrGeneProduct denotes IMPACT

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 87-102 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T2 103-113 DiseaseOrPhenotypicFeature denotes recurrence D012008
T3 328-338 DiseaseOrPhenotypicFeature denotes recurrence D012008
T4 367-382 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T5 505-515 DiseaseOrPhenotypicFeature denotes recurrence D012008
T6 1130-1140 DiseaseOrPhenotypicFeature denotes recurrence D012008
T7 1277-1287 DiseaseOrPhenotypicFeature denotes recurrence D012008
T8 1468-1478 DiseaseOrPhenotypicFeature denotes recurrence D012008
T9 1558-1573 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T10 1574-1584 DiseaseOrPhenotypicFeature denotes recurrence D012008
T11 1725-1740 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T12 1741-1751 DiseaseOrPhenotypicFeature denotes recurrence D012008

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 13-17 GeneOrGeneProduct denotes IL10
T2 216-220 GeneOrGeneProduct denotes IL10
T3 560-564 GeneOrGeneProduct denotes race
T4 736-740 GeneOrGeneProduct denotes IL10
T5 747-751 GeneOrGeneProduct denotes GPX1
T6 758-763 GeneOrGeneProduct denotes GSTP1
T7 765-770 GeneOrGeneProduct denotes hOGG1
T8 772-776 GeneOrGeneProduct denotes IL1B
T9 778-783 GeneOrGeneProduct denotes IL1RN
T10 785-788 GeneOrGeneProduct denotes IL6
T11 790-793 GeneOrGeneProduct denotes IL8
T12 800-804 GeneOrGeneProduct denotes NOS2
T13 806-810 GeneOrGeneProduct denotes NOS3
T14 812-816 GeneOrGeneProduct denotes SOD1
T15 818-822 GeneOrGeneProduct denotes SOD2
T16 824-828 GeneOrGeneProduct denotes SOD3
T17 830-834 GeneOrGeneProduct denotes TLR4
T18 864-868 GeneOrGeneProduct denotes IL10
T19 880-885 GeneOrGeneProduct denotes IL1RN
T20 887-890 GeneOrGeneProduct denotes IL6
T21 892-896 GeneOrGeneProduct denotes NOS2
T22 902-906 GeneOrGeneProduct denotes NOS3
T23 1031-1035 GeneOrGeneProduct denotes IL10
T24 1069-1083 GeneOrGeneProduct denotes interleukin-10
T25 1085-1090 GeneOrGeneProduct denotes IL-10
T26 1234-1239 GeneOrGeneProduct denotes IL-10
T27 1377-1382 GeneOrGeneProduct denotes GSTP1
T28 1388-1392 GeneOrGeneProduct denotes IL1B
T29 1403-1407 GeneOrGeneProduct denotes IL10
T30 1431-1435 GeneOrGeneProduct denotes NOS2
T31 1505-1509 GeneOrGeneProduct denotes IL10
T32 1516-1521 GeneOrGeneProduct denotes GSTP1
T33 1523-1527 GeneOrGeneProduct denotes IL1B
T34 1533-1537 GeneOrGeneProduct denotes NOS2
T35 1631-1637 GeneOrGeneProduct denotes IMPACT

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 87-102 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T2 367-382 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T3 437-440 DiseaseOrPhenotypicFeature denotes men 0017169
T4 1558-1573 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315
T5 1725-1740 DiseaseOrPhenotypicFeature denotes prostate cancer 0008315

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 87-102 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T2 103-113 DiseaseOrPhenotypicFeature denotes recurrence D012008
T3 328-338 DiseaseOrPhenotypicFeature denotes recurrence D012008
T4 367-382 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T5 505-515 DiseaseOrPhenotypicFeature denotes recurrence D012008
T6 1130-1140 DiseaseOrPhenotypicFeature denotes recurrence D012008
T7 1277-1287 DiseaseOrPhenotypicFeature denotes recurrence D012008
T8 1468-1478 DiseaseOrPhenotypicFeature denotes recurrence D012008
T9 1558-1573 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T10 1574-1584 DiseaseOrPhenotypicFeature denotes recurrence D012008
T11 1725-1740 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T12 1741-1751 DiseaseOrPhenotypicFeature denotes recurrence D012008

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 87-102 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T2 367-382 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T3 1558-1573 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T4 1725-1740 DiseaseOrPhenotypicFeature denotes prostate cancer D011471

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 255-278 ChemicalEntity denotes reactive oxygen species D017382|http://purl.obolibrary.org/obo/CHEBI_26523
T3 451-458 ChemicalEntity denotes radical http://purl.obolibrary.org/obo/CHEBI_26519
T4 630-638 ChemicalEntity denotes paraffin D010232|ChemicalEntity
T6 790-793 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 437-440 OrganismTaxon denotes men

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T6 790-793 ChemicalEntity denotes IL8 http://purl.obolibrary.org/obo/CHEBI_138181
T4 630-638 ChemicalEntity denotes paraffin ChemicalEntity|D010232
T3 451-458 ChemicalEntity denotes radical http://purl.obolibrary.org/obo/CHEBI_26519
T1 255-278 ChemicalEntity denotes reactive oxygen species http://purl.obolibrary.org/obo/CHEBI_26523|D017382
T35 1631-1637 GeneOrGeneProduct denotes IMPACT
T34 1533-1537 GeneOrGeneProduct denotes NOS2
T33 1523-1527 GeneOrGeneProduct denotes IL1B
T32 1516-1521 GeneOrGeneProduct denotes GSTP1
T31 1505-1509 GeneOrGeneProduct denotes IL10
T30 1431-1435 GeneOrGeneProduct denotes NOS2
T29 1403-1407 GeneOrGeneProduct denotes IL10
T28 1388-1392 GeneOrGeneProduct denotes IL1B
T27 1377-1382 GeneOrGeneProduct denotes GSTP1
T26 1234-1239 GeneOrGeneProduct denotes IL-10
T25 1085-1090 GeneOrGeneProduct denotes IL-10
T24 1069-1083 GeneOrGeneProduct denotes interleukin-10
T23 1031-1035 GeneOrGeneProduct denotes IL10
T22 902-906 GeneOrGeneProduct denotes NOS3
T21 892-896 GeneOrGeneProduct denotes NOS2
T20 887-890 GeneOrGeneProduct denotes IL6
T19 880-885 GeneOrGeneProduct denotes IL1RN
T18 864-868 GeneOrGeneProduct denotes IL10
T17 830-834 GeneOrGeneProduct denotes TLR4
T16 824-828 GeneOrGeneProduct denotes SOD3
T15 818-822 GeneOrGeneProduct denotes SOD2
T14 812-816 GeneOrGeneProduct denotes SOD1
T13 806-810 GeneOrGeneProduct denotes NOS3
T12 800-804 GeneOrGeneProduct denotes NOS2
T11 790-793 GeneOrGeneProduct denotes IL8
T10 785-788 GeneOrGeneProduct denotes IL6
T9 778-783 GeneOrGeneProduct denotes IL1RN
T8 772-776 GeneOrGeneProduct denotes IL1B
T7 765-770 GeneOrGeneProduct denotes hOGG1
T57514 758-763 GeneOrGeneProduct denotes GSTP1
T5 747-751 GeneOrGeneProduct denotes GPX1
T60170 736-740 GeneOrGeneProduct denotes IL10
T82601 560-564 GeneOrGeneProduct denotes race
T2 216-220 GeneOrGeneProduct denotes IL10
T26036 13-17 GeneOrGeneProduct denotes IL10
T89767 1725-1740 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T97717 1558-1573 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T4850 367-382 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T34746 87-102 DiseaseOrPhenotypicFeature denotes prostate cancer D011471
T8545 437-440 OrganismTaxon denotes men
T42468 1201-1210 SequenceVariant denotes rs1800896
T16711 1036-1045 SequenceVariant denotes rs1800872

DisGeNET

Id Subject Object Predicate Lexical cue
T0 1523-1527 gene:3553 denotes IL1B
T1 1558-1573 disease:C0376358 denotes prostate cancer
T2 1523-1527 gene:3553 denotes IL1B
T3 1558-1573 disease:C0600139 denotes prostate cancer
T4 1533-1537 gene:339345 denotes NOS2
T5 1558-1573 disease:C0376358 denotes prostate cancer
T6 1533-1537 gene:339345 denotes NOS2
T7 1558-1573 disease:C0600139 denotes prostate cancer
T8 1533-1537 gene:4843 denotes NOS2
T9 1558-1573 disease:C0376358 denotes prostate cancer
T10 1533-1537 gene:4843 denotes NOS2
T11 1558-1573 disease:C0600139 denotes prostate cancer
T12 1533-1537 gene:339345 denotes NOS2
T13 1574-1584 disease:C1458156 denotes recurrence
T14 1533-1537 gene:4843 denotes NOS2
T15 1574-1584 disease:C1458156 denotes recurrence
R1 T0 T1 associated_with IL1B,prostate cancer
R2 T2 T3 associated_with IL1B,prostate cancer
R3 T4 T5 associated_with NOS2,prostate cancer
R4 T6 T7 associated_with NOS2,prostate cancer
R5 T8 T9 associated_with NOS2,prostate cancer
R6 T10 T11 associated_with NOS2,prostate cancer
R7 T12 T13 associated_with NOS2,recurrence
R8 T14 T15 associated_with NOS2,recurrence

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 367-382 HP_0012125 denotes prostate cancer
T2 376-382 HP_0002664 denotes cancer

Allie

Id Subject Object Predicate Lexical cue
SS1_22859398_7_0 695-726 expanded denotes single-nucleotide polymorphisms
SS2_22859398_7_0 728-731 abbr denotes SNP
SS1_22859398_8_0 971-991 expanded denotes confidence intervals
SS2_22859398_8_0 993-995 abbr denotes CI
SS1_22859398_10_0 1069-1083 expanded denotes interleukin-10
SS2_22859398_10_0 1085-1090 abbr denotes IL-10
AE1_22859398_7_0 SS1_22859398_7_0 SS2_22859398_7_0 abbreviatedTo single-nucleotide polymorphisms,SNP
AE1_22859398_8_0 SS1_22859398_8_0 SS2_22859398_8_0 abbreviatedTo confidence intervals,CI
AE1_22859398_10_0 SS1_22859398_10_0 SS2_22859398_10_0 abbreviatedTo interleukin-10,IL-10

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
22859398-0#13#17#gene3586 13-17 gene3586 denotes IL10
22859398-0#87#102#diseaseC0376358 87-102 diseaseC0376358 denotes prostate cancer
22859398-0#87#102#diseaseC0600139 87-102 diseaseC0600139 denotes prostate cancer
22859398-10#41#45#gene4843 1533-1537 gene4843 denotes NOS2
22859398-10#66#81#diseaseC0376358 1558-1573 diseaseC0376358 denotes prostate cancer
22859398-10#66#81#diseaseC0600139 1558-1573 diseaseC0600139 denotes prostate cancer
13#17#gene358687#102#diseaseC0376358 22859398-0#13#17#gene3586 22859398-0#87#102#diseaseC0376358 associated_with IL10,prostate cancer
13#17#gene358687#102#diseaseC0600139 22859398-0#13#17#gene3586 22859398-0#87#102#diseaseC0600139 associated_with IL10,prostate cancer
41#45#gene484366#81#diseaseC0376358 22859398-10#41#45#gene4843 22859398-10#66#81#diseaseC0376358 associated_with NOS2,prostate cancer
41#45#gene484366#81#diseaseC0600139 22859398-10#41#45#gene4843 22859398-10#66#81#diseaseC0600139 associated_with NOS2,prostate cancer